COVID-19 Update: All AMP Locations are open, see how we are offering safe in person care and virtual visits. Click here to Learn more about Virtual Care Options.

Click here for additional COVID-19 Information

Non-Discrimination Notice

Myriad URO-012

URO-012 – A Prospective Registry for Hereditary Cancer Risk Assessment and Genetic Testing.

Population:

Among men with prostate cancer in the Community Urology Practice Setting.

Sponsored by: Myriad
Enrollment: Open

Please contact one of our Clinical Research Coordinators today to find out more information if you are interested in this trial.

Research Department (315) 478-4185, option 3